CRNP, MSN, OCN
Goal and Learning Outcomes
At the conclusion of the activity, learners should be better able to:
- Review the primary pathways that result in CINV
- Recommend antiemetic strategies for specific types of CINV based upon patient history
- Develop and apply patient educational tactics to help improve CINV outcomes
Released On: 8/15/2018
Expires On: 8/15/2019
Media type: Internet
Completion time: 60-minutes
Oncology Nurses and Nurse Practitioners
Chemotherapy-Induced Nausea and Vomiting
Nurses/NPs — 1.0 contact hours. (0.75 pharmacotherapeutic contact hours)
All other health care professionals completing this course will be issued a statement of participation.
This activity is designed for oncology nursing professionals engaged in care of patients experiencing or at-risk for chemotherapy-induced nausea and vomiting.
American Academy of CME, Inc., designates this educational activity for 1.0 contact hours. (0.75 pharmacotherapeutic contact hours)
Disclosures of Conflicts of Interest
This educational activity may contain discussion of published and/or investigational uses of agents not indicated by the FDA. Faculty have been asked to disclose off-label and/or investigational uses if they are mentioned. Please refer to official prescribing information for each product for discussion of approved indications, contraindications, and warnings. American Academy of CME requires faculty to provide the level of evidence for patient care recommendation made during their presentations.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Ms. Sandy discloses the following:
Consultant for marketing – AbbVie
Promotional speakers bureau – Merck, Helsinn, Takeda, AstraZeneca
This activity includes discussion of unapproved uses of approved agents and investigational agents.
The planning committee consisting of Wendy Gloffke, Ph.D.; Natalie Kirkwood B.S.N., J.D. (Lead Nurse Planner); Paul Miniter, MS have no financial disclosures to report.
This activity is provided by American Academy of CME, Inc.
American Academy of CME, Inc, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
American Academy of CME, Inc is a provider of California Board of Nursing credit. California provider number CEP16993.
Supported by an educational grant from Merck.
Method of Participation
There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive credit for participation, participants must complete the posttest (achieving a passing grade of 70% minimum) and program evaluation. Certificates can be printed immediately.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
For any questions, please contact: CEServices@academycme.org.
©2018. This CNE-certified activity is held as copyrighted © by American Academy of CME. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).